Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Head & Neck 1

Conditions

Lung Neoplasms 2Tuberous Sclerosis 1Smoking 1Neoplasms 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphangioleiomyomatosis 1Lip Neoplasms 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Endocrine Gland Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Phlebotomy × Clear all
NCT03881098 2026-01-29

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

University of Colorado, Denver

Phase NA Recruiting
240 enrolled
Thoracic

Carcinoma, Squamous Cell, Lung Neoplasms, Smoking

NCT00568490 2025-07-02

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Stanford University

Recruiting
200 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lip Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡